However, other studies focusing on the premenopausal population underline that early-onset breast cancer cannot be attributed to TP53 polymorphisms alone, although specific mutations occur in this young cohort in higher frequency, without, however, always affecting p53 transactivation function [45]. Here, TP53 is linked to breast carcinoma.